Persistent neurological symptoms and cognitive dysfunction in non-hospitalized Covid – 19 “long guards” – Graham – – Annals of clinical and translational neurology
Experimental drugs against Alzheimer’s may delay cognitive decline in patients, early results indicate
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/6SAQTDRWTJATDONKJ23AULXLTQ.jpg "The unsecured sue decreases by 25% the cognitive yield in the medicines, following a study")
